Login
Super Investors / BRUCE FUND

BRUCE FUND

Bruce Fund, Inc. · net assets $376M · 43 holdings as of June 30, 2026. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

EC: 91.5% · STIV: 4.6% · DBT: 3.9%

Financial position

Total assets
$376M
Total liabilities
$238K
Net assets
$376M
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$0
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0
Cash not reported in Parts C or D
$0

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $81K $26.5K $646K
Reinvestment $0 $0 $0
Redemptions $3.21M $1.94M $6.82M
Net realized gain (non-derivative) $2.86M $1.24M $432K
Net unrealized appreciation (non-derivative) $3.22M $2.27M $13.5M

The three months of the reporting period, as filed; month 3 ends June 30, 2026.

Filing details

Registrant
Bruce Fund, Inc.
Registrant CIK
47071
Registrant LEI
549300KR3RLFC5M6KA98
Series
BRUCE FUND
Series ID
S000011411
Series LEI
549300KR3RLFC5M6KA98
SEC file number
811-01528
Address
20 N. Wacker Dr., Suite 2414, Chicago, US-IL, 60606, US
Phone
312-236-9160
Form
NPORT-P
Filed
August 31, 2026
Report period ends
June 30, 2026
Report month ends
June 30, 2026
Accession number
000091047226014086
Holding Value % of net assets
Aercap Holdings Nv EC $26.2M 6.98%
Allstate Corp (the) EC $26.2M 6.96%
Abbvie Inc EC $25.2M 6.70%
Merck & Company Inc EC $23.1M 6.15%
Nextera Energy Inc EC $22.8M 6.07%
U-haul Holding Company EC $20.8M 5.53%
Vicor Corp EC $18.2M 4.85%
Duke Energy Corp EC $17.7M 4.72%
Morgan Stanley Institutional Liquidity Funds STIV $17.5M 4.64%
Xcel Energy Inc EC $14.5M 3.85%
United States Of America - Bureau Of The Public Debt DBT $13.3M 3.53%
Cms Energy Corp EC $11.5M 3.05%
Beta Bionics Inc EC $10.4M 2.78%
Insteel Industries Inc EC $10.4M 2.76%
Abbott Laboratories EC $9.98M 2.66%
Newmont Corp EC $9.34M 2.49%
AT&T Inc EC $9.32M 2.48%
Apple Inc EC $8.68M 2.31%
Avista Corp EC $8.18M 2.18%
Archer Daniels Midland Company EC $7.64M 2.03%
Bunge Global Sa EC $7.47M 1.99%
Supernus Pharmaceuticals Inc EC $6.98M 1.86%
Pfizer Inc EC $6.02M 1.60%
Kodiak Sciences Inc EC $5.65M 1.50%
Darling Ingredients Inc EC $5.19M 1.38%
Chemours Company (the) EC $5.13M 1.36%
U-haul Holding Company EC $4.45M 1.18%
Lyondellbasell Industries Nv EC $3.16M 0.84%
Personalis Inc EC $3.12M 0.83%
Fate Therapeutics Inc EC $2.67M 0.71%
Eli Lilly & Company EC $2.4M 0.64%
Apogee Enterprises Inc EC $2.29M 0.61%
Edap Tms Sa EC $2.15M 0.57%
Sirius Xm Holdings Inc EC $1.65M 0.44%
United States Of America - Bureau Of The Public Debt DBT $1.31M 0.35%
Venture Global Inc EC $1.11M 0.30%
Ashland Inc EC $988K 0.26%
Viatris Inc EC $887K 0.24%
Mannkind Corp EC $831K 0.22%
908 Devices Inc EC $594K 0.16%
Caribou Biosciences Inc EC $440K 0.12%
Bausch Health Companies Inc EC $247K 0.07%
Acorda Therapeutics Inc DBT $25K 0.01%

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support